BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 25733509)

  • 1. Pharmacokinetics and safety of intravenous cidofovir for life-threatening viral infections in pediatric hematopoietic stem cell transplant recipients.
    Caruso Brown AE; Cohen MN; Tong S; Braverman RS; Rooney JF; Giller R; Levin MJ
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3718-25. PubMed ID: 25733509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of cidofovir on adenovirus plasma DNA levels in stem cell transplantation recipients without T cell reconstitution.
    Lugthart G; Oomen MA; Jol-van der Zijde CM; Ball LM; Bresters D; Kollen WJ; Smiers FJ; Vermont CL; Bredius RG; Schilham MW; van Tol MJ; Lankester AC
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):293-9. PubMed ID: 25464118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of BK virus-associated hemorrhagic cystitis with low-dose intravenous cidofovir in patients undergoing allogeneic hematopoietic cell transplantation.
    Lee SS; Ahn JS; Jung SH; Ahn SY; Kim JY; Jang HC; Kang SJ; Jang MO; Yang DH; Kim YK; Lee JJ; Kim HJ
    Korean J Intern Med; 2015 Mar; 30(2):212-8. PubMed ID: 25750563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal Toxicity in Pediatric Patients Receiving Cidofovir for the Treatment of Adenovirus Infection.
    Vora SB; Brothers AW; Englund JA
    J Pediatric Infect Dis Soc; 2017 Nov; 6(4):399-402. PubMed ID: 28419263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients.
    Muller WJ; Levin MJ; Shin YK; Robinson C; Quinones R; Malcolm J; Hild E; Gao D; Giller R
    Clin Infect Dis; 2005 Dec; 41(12):1812-6. PubMed ID: 16288409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience.
    El-Haddad D; El Chaer F; Vanichanan J; Shah DP; Ariza-Heredia EJ; Mulanovich VE; Gulbis AM; Shpall EJ; Chemaly RF
    Antiviral Res; 2016 Oct; 134():58-62. PubMed ID: 27582067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose cidofovir in the treatment of symptomatic BK virus infection in patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis of an algorithmic approach.
    Ganguly N; Clough LA; Dubois LK; Mcguirk JP; Abhyankar S; Aljitawi OS; O'Neal N; Divine CL; Ganguly S
    Transpl Infect Dis; 2010 Oct; 12(5):406-11. PubMed ID: 20487411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability of cidofovir in high-risk pediatric patients.
    Bhadri VA; Lee-Horn L; Shaw PJ
    Transpl Infect Dis; 2009 Aug; 11(4):373-9. PubMed ID: 19392729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study.
    Cesaro S; Hirsch HH; Faraci M; Owoc-Lempach J; Beltrame A; Tendas A; Baltadakis I; Dalle JH; Koc Y; Toporski J; Styczynski J; Yesilipek MA; Heinz W; Caniglia M; Rascon J; Fauser AA; Michallet M; Lopez-Corral L; Neuburger S; Tridello G; Einsele H;
    Clin Infect Dis; 2009 Jul; 49(2):233-40. PubMed ID: 19522651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation.
    Philippe M; Ranchon F; Gilis L; Schwiertz V; Vantard N; Ader F; Labussiere-Wallet H; Thomas X; Nicolini FE; Wattel E; Ducastelle-Leprêtre S; Barraco F; Lebras L; Salles G; Michallet M; Rioufol C
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):723-730. PubMed ID: 26718666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir.
    Symeonidis N; Jakubowski A; Pierre-Louis S; Jaffe D; Pamer E; Sepkowitz K; O'Reilly RJ; Papanicolaou GA
    Transpl Infect Dis; 2007 Jun; 9(2):108-13. PubMed ID: 17461995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients.
    Yusuf U; Hale GA; Carr J; Gu Z; Benaim E; Woodard P; Kasow KA; Horwitz EM; Leung W; Srivastava DK; Handgretinger R; Hayden RT
    Transplantation; 2006 May; 81(10):1398-404. PubMed ID: 16732176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of BK virus-associated hemorrhagic cystitis in pediatric hematopoietic stem cell transplant recipients with cidofovir: a single-center experience.
    Kwon HJ; Kang JH; Lee JW; Chung NG; Kim HK; Cho B
    Transpl Infect Dis; 2013 Dec; 15(6):569-74. PubMed ID: 24028353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and safety of intravesicular cidofovir in allogeneic HSCT recipients.
    Aitken SL; Zhou J; Ghantoji SS; Kontoyiannis DP; Jones RB; Tam VH; Chemaly RF
    J Antimicrob Chemother; 2016 Mar; 71(3):727-30. PubMed ID: 26612873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cidofovir for cytomegalovirus reactivation in pediatric patients after hematopoietic stem cell transplantation.
    Cesaro S; Zhou X; Manzardo C; Buonfrate D; Cusinato R; Tridello G; Mengoli C; Palù G; Messina C
    J Clin Virol; 2005 Oct; 34(2):129-32. PubMed ID: 16157264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravesicular cidofovir for BK hemorrhagic cystitis in pediatric patients after hematopoietic stem cell transplant.
    Foster JH; Cheng WS; Nguyen NY; Krance R; Martinez C
    Pediatr Transplant; 2018 May; 22(3):e13141. PubMed ID: 29388318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection.
    Momper JD; Zhao Y; Shapiro R; Schonder KS; Gao Y; Randhawa PS; Venkataramanan R
    Transpl Infect Dis; 2013 Feb; 15(1):34-41. PubMed ID: 23025519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-onset hemorrhagic cystitis in children after hematopoietic stem cell transplantation for thalassemia and sickle cell anemia: a prospective evaluation of polyoma (BK) virus infection and treatment with cidofovir.
    Gaziev J; Paba P; Miano R; Germani S; Sodani P; Bove P; Perno CF; Marziali M; Gallucci C; Isgrò A; Paciaroni K; Roveda A; Simone MD; De Angelis G; Alfieri C; Lucarelli G
    Biol Blood Marrow Transplant; 2010 May; 16(5):662-71. PubMed ID: 20026413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
    Ljungman P; Ribaud P; Eyrich M; Matthes-Martin S; Einsele H; Bleakley M; Machaczka M; Bierings M; Bosi A; Gratecos N; Cordonnier C;
    Bone Marrow Transplant; 2003 Mar; 31(6):481-6. PubMed ID: 12665844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation.
    Voigt S; Hofmann J; Edelmann A; Sauerbrei A; Kühl JS
    Transpl Infect Dis; 2016 Oct; 18(5):791-794. PubMed ID: 27482652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.